Y. Yoshida

Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.

S. Yamashita, Y. Matsuzawa, T. Arai, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Molecular Defect and Atherogenicity in Cholesteryl Ester Transfer Protein Deficiency

S. Yamashita, Y. Matsuzawa, T. Arai, 1994, Annals of the New York Academy of Sciences.

Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects.

S. Yamashita, M. Menju, T. Arai, 1995, Atherosclerosis.

Expression and functional analyses of novel mutations of ATP-binding cassette transporter-1 in Japanese patients with high-density lipoprotein deficiency.

M. Hayden, S. Yamashita, Y. Matsuzawa, 2002, Biochemical and biophysical research communications.

Marked hyperalphalipoproteinemia is not a longevity syndrome. Insights from a cohort study in a city where CETP deficiency accumulates

S. Yamashita, Y. Matsuzawa, T. Arai, 1994 .